Valirx (VAL)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1.33p
   
  • Change Today:
    -0.017p
  • 52 Week High: 14.13
  • 52 Week Low: 1.33
  • Currency: UK Pounds
  • Shares Issued: 132.35m
  • Volume: 11,220
  • Market Cap: £1.76m
  • RiskGrade: 435
  • Beta: 0.06

Valirx Overview

ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -22990.0% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 178.7 n/a
Pr/Book 0.6  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Valirx Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 n/a (2.72) (4,135.00)p n/a n/a n/a n/a 0.0%
31-Dec-20 n/a (1.54) (3.81)p n/a n/a n/a n/a 0.0%
31-Dec-21 n/a (1.68) (2.34)p n/a n/a n/a n/a 0.0%
31-Dec-22 n/a (2.60) (3.06)p n/a n/a n/a n/a 0.0%
31-Dec-23 0.01 (2.30) (2.01)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Valirx Company Announcements

Inaphaea Co-Marketing Agreement 07-Oct-2024 07:00 RNS
Half-year Report 27-Sep-2024 07:00 RNS
Conclusion of Evaluation Project 26-Sep-2024 07:00 RNS

Valirx ShareCast News

ValiRx losses narrow in first half 27-Sep-2024 ShareCast
ValiRx pulls out of University of Barcelona coll... 26-Sep-2024 ShareCast
ValiRx subsidiary inks agreement with research f... 18-Sep-2024 ShareCast

Valirx Top Newspaper Links

Business Digest 24-Sep-2006 Sunday Times

Latest Valirx Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Valirx Market Data

Currency UK Pounds
Share Price 1.33p
Change Today -0.017p
% Change -1.23 %
52 Week High 14.13
52 Week Low 1.33
Volume 11,220
Shares Issued 132.35m
Market Cap £1.76m
Beta 0.06
RiskGrade 435

Valirx Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
25.29% above the market average25.29% above the market average25.29% above the market average25.29% above the market average25.29% above the market average
16.00% above the sector average16.00% above the sector average16.00% above the sector average16.00% above the sector average16.00% above the sector average
Price Trend
95.58% below the market average95.58% below the market average95.58% below the market average95.58% below the market average95.58% below the market average
96% below the sector average96% below the sector average96% below the sector average96% below the sector average96% below the sector average
Income Not Available
Growth Not Available

Valirx Dividends

No dividends found

Trades for 07-Oct-2024

Time Volume / Share Price
08:11 3,220 @ 1.37p
08:09 8,000 @ 1.37p

Valirx Key Personnel

CFO Gerald Desler

Top of Page